C. Tallant

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains

Duncan A. Hay, Oleg Fedorov, Sarah Martin et al. · Journal of the American Chemical Society · 2014 · 281 citations · Full text

Combinatorial Chemistry, Molecular Biology, Lead Identification +19

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Ariane Hammitzsch, C. Tallant, O. Fedorov et al. · Proceedings of the National Academy of Sciences · 2015 · 252 citations · Full text

Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

Laetitia J. Martin, Manfred Koegl, Gerd Bader et al. · Journal of Medicinal Chemistry · 2016 · 219 citations · Full text

Molecular Biology, Cancer Biology, Tumor Biology +17

LP99: Discovery and Synthesis of the First Selective BRD7/9 Bromodomain Inhibitor

Peter G. K. Clark, Lucas Campos Curcino Vieira, C. Tallant et al. · Angewandte Chemie International Edition · 2015 · 162 citations · Full text

Lead Scaffold, Molecular Pharmacology, Medicinal Chemistry +15

Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B

Peiling Chen, A. Chaikuad, Paul Bamborough et al. · Journal of Medicinal Chemistry · 2015 · 160 citations · Full text

Baz2 Bromodomains, Protein Assembly, Molecular Biology +16